Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Harrison

Showing results (41-50 of 583) with videos related to

Pageof 59
Sort By:
Hematology/Oncology Clinics of North America|March 30, 2011
Myeloproliferative disorders in pregnancyClaire N Harrison, Susan E Robinson
Thorax|November 1, 1980
Effect of acute and chronic beta-blockade on carbon dioxide sensitivity in normal manP F Hutchinson, R N Harrison
Thorax|January 1, 1984
Airway response to inhaled salbutamol in hyperthyroid and hypothyroid patients before and after treatmentR N Harrison, A E Tattersfield
British Journal of Haematology|March 10, 2020
How we manage Philadelphia-negative myeloproliferative neoplasms in pregnancySusan E Robinson, Claire N Harrison
The American Journal of Medicine|March 1, 1997
Antiphospholipid antibodies and essential thrombocythemiaC N Harrison, S J Machin
Hematology. American Society of Hematology. Education Program|December 10, 2017
Current treatment algorithm for the management of patients with myelofibrosis, JAK inhibitors, and beyondClaire N Harrison, Donal P McLornan
Blood|December 29, 2016
Emerging treatments for classical myeloproliferative neoplasmsAlessandro M Vannucchi, Claire N Harrison
Molecular and Cellular Endocrinology|February 8, 2017
JAK-STAT signaling in the therapeutic landscape of myeloproliferative neoplasmsJennifer M O'Sullivan, Claire N Harrison
Expert Opinion on Pharmacotherapy|April 1, 2026
Combination treatments for myelofibrosis in jak inhibitor-naive patients: evidence, rationale, and clinical directionLaura Li Gagnon, Claire N Harrison
Health Trends|December 9, 1992
Comparison of the quality of patient data collected by hospital and departmental computer systemsK Walshe, N Harrison, M Renshaw
Pageof 59

Showing results (41-50 of 583) with videos related to

Sort By:
Pageof 59
Hematology/Oncology Clinics of North America|March 30, 2011
Myeloproliferative disorders in pregnancyClaire N Harrison, Susan E Robinson
Thorax|November 1, 1980
Effect of acute and chronic beta-blockade on carbon dioxide sensitivity in normal manP F Hutchinson, R N Harrison
Thorax|January 1, 1984
Airway response to inhaled salbutamol in hyperthyroid and hypothyroid patients before and after treatmentR N Harrison, A E Tattersfield
British Journal of Haematology|March 10, 2020
How we manage Philadelphia-negative myeloproliferative neoplasms in pregnancySusan E Robinson, Claire N Harrison
The American Journal of Medicine|March 1, 1997
Antiphospholipid antibodies and essential thrombocythemiaC N Harrison, S J Machin
Hematology. American Society of Hematology. Education Program|December 10, 2017
Current treatment algorithm for the management of patients with myelofibrosis, JAK inhibitors, and beyondClaire N Harrison, Donal P McLornan
Blood|December 29, 2016
Emerging treatments for classical myeloproliferative neoplasmsAlessandro M Vannucchi, Claire N Harrison
Molecular and Cellular Endocrinology|February 8, 2017
JAK-STAT signaling in the therapeutic landscape of myeloproliferative neoplasmsJennifer M O'Sullivan, Claire N Harrison
Expert Opinion on Pharmacotherapy|April 1, 2026
Combination treatments for myelofibrosis in jak inhibitor-naive patients: evidence, rationale, and clinical directionLaura Li Gagnon, Claire N Harrison
Health Trends|December 9, 1992
Comparison of the quality of patient data collected by hospital and departmental computer systemsK Walshe, N Harrison, M Renshaw
Pageof 59